echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > The Fortune Global 500 Summit was held in Hangzhou, Guangyao Li Chuyuan: Fulfilling the Mission of Traditional Chinese Medicine for Human Health

    The Fortune Global 500 Summit was held in Hangzhou, Guangyao Li Chuyuan: Fulfilling the Mission of Traditional Chinese Medicine for Human Health

    • Last Update: 2021-11-04
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Hangzhou, October 20, 2021/PRNewswire/ - On October 19, the 2021 Fortune Global 500 Summit was grandly held in Hangzhou.


    As the first Chinese company to enter the world's top 500 with traditional Chinese medicine as its main business, Li Chuyuan, secretary of the party committee and chairman of Guangyao Group, was invited to participate in the summit and competed with other Fortune 500 companies in the "Role of Large Companies in Crisis" roundtable forum.


    Scene of Fortune Global 500 Hangzhou Summit

    The summit will be conducted mainly offline and combined online, and some international guests will participate in the form of video


    Li Chuyuan: A great remedy for the epidemic, Chinese medicine contributes Chinese wisdom to the fight against the new crown epidemic

    As a newcomer to the Fortune Global 500 this year, Guangyao Group has become the first company in the world to enter the Fortune Global 500 with Chinese medicine as its main business.


    "The new crown epidemic is a crisis, but the crisis is organic.


    Executives from Pfizer, Medtronic and Pacific Insurance and Guangzhou Pharmaceutical Group discussed the "Role and Responsibilities of Large Companies in Crisis" at the roundtable forum


    Roundtable Forum on “Role and Responsibilities of Large Companies in Crisis” at Hangzhou Summit of Fortune 500

    In the process of clinical treatment of the new crown pneumonia epidemic, Chinese medicine has been involved very early and played an important role


    "The State Administration of Traditional Chinese Medicine always mentions'three prescriptions and three medicines' for treating patients before they are ill.


    Li Chuyuan, Secretary of the Party Committee and Chairman of Guangzhou Pharmaceutical Group, made a speech in the roundtable discussion

    As China’s largest pharmaceutical company and a leading company with traditional Chinese medicine as its main business, since the beginning of 2020, the epidemic has been raging, Guangyao Group has the obligation to join the epidemic prevention and anti-epidemic work, and took the lead in proposing the responsibility commitment of “no two guarantees”, that is, no suspension of work, Do not increase prices, ensure product quality, ensure that public welfare is paramount, and work overtime to produce medical and medical supplies, building an "invisible supply line" for epidemic prevention and control


    According to statistics, during the epidemic last year, Guangzhou Pharmaceutical Group supplied more than 120 million pieces of anti-epidemic protection related materials, and the "Suikang" platform cooperated with the government to provide more than 300 million masks for 15 million people


    Over the years, Guangyao Group has continued to cultivate in the traditional Chinese medicine industry and is committed to the cause of human health


    At the summit, "Fortune" magazine issued a Fortune 500 certificate to Guangzhou Pharmaceutical Group

    "Fashion Chinese Medicine" provides "Guangdong Medicine Program" for global health

    With the strong support of policies such as the "new development pattern with domestic and international cycles as the mainstay and mutual promotion of domestic and international double cycles" planned by the party and the state, and the "Opinions of the Central Committee of the Communist Party of China and the State Council on Promoting the Inheritance and Innovation and Development of Traditional Chinese Medicine," and other policies, it faces increasing China’s traditional Chinese medicine industry has ushered in a new pattern and new opportunity to create a “long board advantage”, further develop the domestic market, and go global


    At the summit, Li Chuyuan talked about his own views on the development trend of Chinese medicine.


    Guangyao Group owns 12 Chinese time-honored brands.


    "You can see that Wanglaoji at our summit is a representative of fashionable Chinese medicine.


    Wang Laoji and Ci Ning Ji at the Fortune Global 500 Hangzhou Summit

    For a long time, Guangyao Group has continued to explore the path of inheritance and innovation of Chinese medicine


    Li Chuyuan believes that traditional Chinese medicine has good development prospects, especially through cross-border innovation, in-depth integration with food, clothing, housing and transportation
    .
    "Through cross-industry cooperation between traditional Chinese medicine and multiple industries, promoting the organic integration of traditional Chinese medicine and clothing, food, housing and transportation, forming a consumer fashion, is a new path for the development of traditional Chinese medicine, and it is also one of the new economy and new industries after the epidemic
    .
    "

    Wang Laoji assists Guangzhou Pharmaceutical on the list of the world's top 500, the next step for Guangzhou Pharmaceutical to take a ship to go to sea to speed up internationalization

    According to reports, Guangyao Group has deployed four major sectors, namely Danan Pharmaceutical, Dahealth, Da Commerce, and Da Medical ten years ago, to drive development.
    Among them, Guangzhou Wanglaoji Da Health Industry Co.
    , Ltd.
    is the core of the health industry sector, which has achieved continuous development for many years.
    High-quality growth.
    From 2012 to 2020, the compound annual growth rate of operating income will be 18.
    97%, and the compound annual growth rate of net profit will be 57.
    89%
    .
    Since the outbreak of the epidemic, Wanglaoji has overcome difficulties in health and achieved sustained growth through product innovation, market innovation and business model innovation, and contributed to the core strength of Guangzhou Pharmaceutical Group's entry into the world's top 500
    .

    In recent years, Wanglaoji has adhered to the innovative concept of "diversified single products and diversified categories".
    Not only sugar-free herbal tea, black herbal tea, jasmine herbal tea and other products have always been leading the development of herbal tea industry, but also launched the coconut soft raw squeezed coconut juice and citrus lemon juice.
    A variety of plant beverages such as series products, especially Ci Ning Ji series products, have become a new benchmark for innovation in the beverage industry
    .

    Next, Wong Lo Kat Health Company will focus on plant functional beverages, accelerate diversified layout, maintain the core advantages of high-quality development, and strive to build a first-class global beverage brand and make the world more auspicious
    .

    At the summit, Li Chuyuan particularly emphasized that based on the domestic and international dual-cycle development pattern, Guangyao Group will focus on the corporate strategic goal of "creating a world-class biomedical and health enterprise with unique industrial characteristics and distinctive culture", and is committed to improving The level of human health, lower medical costs, and provide more traditional Chinese medicine solutions for the world’s health
    .

    “Especially the construction of the Guangdong-Hong Kong-Macao Greater Bay Area has given us new major platforms and major opportunities, and injected new and powerful impetus into our creation of new brilliance
    .
    " District construction opportunities, deepen cooperation between Guangdong and Macao, and actively support the development of Macao's pharmaceutical industry
    .
    Guangzhou Pharmaceutical Group has established an international headquarters in Macau.
    The company is positioned as an external window for Guangzhou Pharmaceutical’s international business.
    The Guangdong-Hong Kong-Macao Greater Bay Area cooperation in the pharmaceutical field will facilitate the moderately diversified economic development of Macau and accelerate the internationalization of the Guangzhou Pharmaceutical Group
    .

    Source: Guangzhou Wanglaojida Health Industry Co.
    , Ltd.

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.